Virginia ValentineOpen University Press
Fathers with Type 1 Diabetes May Be More Likely to Pass on Disease than Mothers ByPatrick Campbell August 2nd 2024 An analysis of more than 11,000 people with T1D found people were more likely to report an affected father than an affected mother. ...
studies show that if you have brown or black skin, controlling your blood glucose once you're diagnosed is more of a challenge. Black children with type 1 diabetes are also at higher risk ofdepression, diabetes complications, and hospital stays. ...
Choroidal thickness as predictor of subclinical carotid atherosclerosis in adults with type 1 diabetes Esmeralda Castelblanco Ignacio Salvador-Miras Dídac Mauricio ResearchOpen Access11 Mar 2025 Scientific Reports Volume: 15, P: 8360 Islet hormones at the intersection of glucose and amino acid metab...
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B).
What is the prognosis for type 1 diabetes? Research published in the Journal of the American Medical Association reported that people with type 1 diabetes live about 11 years less than average; however, new research also suggests this differential can be reduced with good glycemic control. Most ...
What is the prognosis for type 1 diabetes? Research published in the Journal of the American Medical Association reported that people with type 1 diabetes live about 11 years less than average; however, new research also suggests this differential can be reduced with good glycemic control. Most ...
Type 2 diabetes develops when the body is unable to produce or use insulin. Insulin is a hormone that helps the body process sugar. When there’s not enough insulin, or your body can’t use it properly, the sugar (glucose) levels in your blood rise higher than what’s safe. ...
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII, the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-1868. doi:10.1016/j.ophtha.2008.08.023 PubMedGoogle ScholarCrossref 25. LeCaire TJ, Palta M, ...
Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunot